$238 Million is the total value of Knott David M Jr's 192 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 153.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOOG | Buy | Alphabet Inc-Cl C | $10,790,000 | -12.1% | 112,220 | +1900.0% | 4.54% | -11.9% |
| New | Apollo Global Management, Inc. | $10,463,000 | – | 225,000 | +100.0% | 4.40% | – | |
| MDWT | Buy | Midwest Holding Inc. | $5,163,000 | +21.5% | 390,241 | +10.3% | 2.17% | +21.7% |
| AVDL | Buy | Avadel Pharmaceuticals plc | $1,958,000 | +258.6% | 390,861 | +74.7% | 0.82% | +259.8% |
| CHRS | Buy | Coherus Biosciences, Inc. | $1,922,000 | +42.6% | 200,000 | +7.4% | 0.81% | +42.9% |
| CLMT | New | Calumet Specialty Products Partners, LPcall | $1,473,000 | – | 115,000 | +100.0% | 0.62% | – |
| CDXS | New | Codexis, Inc. | $1,346,000 | – | 222,107 | +100.0% | 0.57% | – |
| FSTX | Buy | F-Star Therapeutics, Inc. | $1,208,000 | +155.9% | 235,945 | +212.7% | 0.51% | +156.6% |
| GSK | New | GlaxoSmithKline plc | $1,177,000 | – | 40,000 | +100.0% | 0.50% | – |
| New | FTAI Infrastructure LLC | $1,020,000 | – | 425,000 | +100.0% | 0.43% | – | |
| VKTX | Buy | Viking Therapeutics, Inc. | $821,000 | +6.5% | 301,803 | +13.1% | 0.34% | +6.5% |
| LPTX | Buy | Leap Therapeutics, Inc. | $792,000 | +68.5% | 900,000 | +120.1% | 0.33% | +69.0% |
| ARDX | New | Ardelyx, Inc. | $774,000 | – | 650,000 | +100.0% | 0.33% | – |
| MDLZ | New | Mondelez International Inc. | $768,000 | – | 14,000 | +100.0% | 0.32% | – |
| SNY | New | Sanofi | $760,000 | – | 20,000 | +100.0% | 0.32% | – |
| MCRB | New | Seres Therapeutics, Inc. | $706,000 | – | 110,000 | +100.0% | 0.30% | – |
| Buy | Aadi Bioscience, Inc. | $693,000 | +300.6% | 49,039 | +249.3% | 0.29% | +300.0% | |
| New | FaZe Holdings Inc. Warrants | $671,000 | – | 58,321 | +100.0% | 0.28% | – | |
| PSTX | New | Poseida Therapeutics, Inc. | $534,000 | – | 151,286 | +100.0% | 0.22% | – |
| MGTX | Buy | MeiraGTx Holdings plc | $507,000 | +29.3% | 60,295 | +16.5% | 0.21% | +29.1% |
| CDTX | Buy | Cidara Therapeutics, Inc. | $431,000 | +39.0% | 686,027 | +8.0% | 0.18% | +39.2% |
| CNCE | New | Concert Pharmaceuticals, Inc. | $335,000 | – | 50,000 | +100.0% | 0.14% | – |
| QTNT | New | Quotient Limited | $245,000 | – | 1,633,492 | +100.0% | 0.10% | – |
| MDGL | New | Madrigal Pharmaaceuticals, Inc. | $65,000 | – | 1,000 | +100.0% | 0.03% | – |
| GOOGL | Buy | Alphabet Inc Class A | $29,000 | -12.1% | 300 | +1900.0% | 0.01% | -14.3% |
| BDX | New | Becton Dickinson & Co. | $24,000 | – | 106 | +100.0% | 0.01% | – |
| PWR | New | Quanta Services Inc. | $22,000 | – | 176 | +100.0% | 0.01% | – |
| GE | New | General Electric Company | $19,000 | – | 312 | +100.0% | 0.01% | – |
| PANW | Buy | Palo Alto Networks Inc. | $17,000 | 0.0% | 102 | +200.0% | 0.01% | 0.0% |
| SPPI | New | Spectrum Pharmaceuticals Inc. | $16,000 | – | 36,900 | +100.0% | 0.01% | – |
| TSLA | Buy | Tesla Inc. | $12,000 | +20.0% | 45 | +200.0% | 0.01% | +25.0% |
| New | Service Properties Trust | $5,000 | – | 1,000 | +100.0% | 0.00% | – | |
| OXYWS | New | Occidential Pertro Wts exp. 8/3/27 | $3,000 | – | 158 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Calumet Specialty Products Partners, LP | 8 | Q3 2023 | 31.5% |
| Alphabet Inc-Cl C | 8 | Q3 2023 | 5.6% |
| DocGo, Inc. | 8 | Q3 2023 | 5.8% |
| Ligand Pharmaceuticals Incorporated | 8 | Q3 2023 | 4.3% |
| Franklin BSP Realty Trust, Inc. | 8 | Q3 2023 | 4.9% |
| Midwest Holding Inc. | 8 | Q3 2023 | 4.1% |
| Coliseum Acquisition Corp.WTS | 8 | Q3 2023 | 2.4% |
| Pfizer Inc. | 8 | Q3 2023 | 3.2% |
| Jazz Pharmaceuticals PLC | 8 | Q3 2023 | 1.5% |
| Vertex Pharmaceuticals, Inc. | 8 | Q3 2023 | 2.1% |
View Knott David M Jr's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Calumet Specialty Products Partners, L.P. | November 08, 2021 | 4,292,200 | 5.4% |
View Knott David M Jr's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-22 |
| SC 13D/A | 2023-12-22 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 4 | 2022-09-26 |
| 4 | 2022-09-02 |
View Knott David M Jr's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.